Home - Products - Others - Other Targets - 24-epi-24-O-acetyl-7,8-didehydrohydroshengmanol-3-O-beta-D-xylopyranoside

24-epi-24-O-acetyl-7,8-didehydrohydroshengmanol-3-O-beta-D-xylopyranoside

CAS No. 228251-25-0

24-epi-24-O-acetyl-7,8-didehydrohydroshengmanol-3-O-beta-D-xylopyranoside( —— )

Catalog No. M32590 CAS No. 228251-25-0

The roots of Cimicifuga foetida L.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 551 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    24-epi-24-O-acetyl-7,8-didehydrohydroshengmanol-3-O-beta-D-xylopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    The roots of Cimicifuga foetida L.
  • Description
    The roots of Cimicifuga foetida L.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    228251-25-0
  • Formula Weight
    678.9
  • Molecular Formula
    C37H58O11
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Butanoic acid, 4-[[2...

    Butanoic acid, 4-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]- is a Cereblon ligand with alkyl linker and terminal acid for onward chemistry.

  • Bepranemab

    Bepranemab (UCB 0107), a humanized full-length IgG4 monoclonal antibody, targets the central tau epitope (amino acids 235-250) and is utilized in Alzheimer’s disease (AD) research .

  • Glaucine

    Glaucine has antitussive antioxidative potential and antiviral activities it may be an anti-arthritic agent it can enhance LPS and zymosan-induced IL-10 production. Glaucine can inhibit the migration and invasion of human breast cancer cells by MMP-9 inhibitory activity attenuating IκBα and NF-κB activities.